Stalevo, a combo product for Parkinson's disease
See FDA information concerning a possible increased cardiovascular risk with Stalevo
Novartis is now marketing Stalevo, a combo product for Parkinson's disease.
It contains both standard-release carbidopa/levodopa (Sinemet, etc)...PLUS entacapone (Comtan).
It's for patients who already take these drugs separately... or for patients who have "wearing-off" on levodopa. Adding entacapone boosts efficacy of levodopa and helps it last longer.